X-ray Micro-tomography Validation of HRCT-Based Airway Measurements. This project brings together a newly emergent modality of microscopy in the form of 3D X-ray micro-tomography (XRMT) along with leading-edge image analysis to develop breakthrough science in respiratory research aimed at improving the reliability of high resolution computed tomography (HRCT). The project will develop novel 3D lung image segmentation protocols, a stereotactic registration program allowing 3D matching of XRCT and ....X-ray Micro-tomography Validation of HRCT-Based Airway Measurements. This project brings together a newly emergent modality of microscopy in the form of 3D X-ray micro-tomography (XRMT) along with leading-edge image analysis to develop breakthrough science in respiratory research aimed at improving the reliability of high resolution computed tomography (HRCT). The project will develop novel 3D lung image segmentation protocols, a stereotactic registration program allowing 3D matching of XRCT and HRCT data sets, and a validation protocol for quantitative HRCT analysis of airway disease. These outcomes will allow wider application of HRCT to non-invasively follow the dynamics of pulmonary function.Read moreRead less
Improving asthma device use: Innovative models for inter-professional practice. This project falls within the goals of National Priority 2: promoting and maintaining good health. This project has the potential to affect every individual accessing health care in the Australia. Through its approach to and focus on improving the use of asthma medications this project will impact on: the quality use of medicines and health outcomes for patients. Through its focus on health professional relationships ....Improving asthma device use: Innovative models for inter-professional practice. This project falls within the goals of National Priority 2: promoting and maintaining good health. This project has the potential to affect every individual accessing health care in the Australia. Through its approach to and focus on improving the use of asthma medications this project will impact on: the quality use of medicines and health outcomes for patients. Through its focus on health professional relationships and interdisciplinary approach to community health care it will result in: improved interprofessional relationships and a model of collaboration which has the potential to be implemented on a broad scale in the community.Read moreRead less
Advanced nanotechnologies for targeting biofilms. Advanced nanotechnologies for targeting biofilms. This project aims to develop nano-particulate systems based on a single platform technology that can be delivered as an aerosol. The current lack of a suitable formulation and delivery system hinders the eradication of fungal and bacterial biofilms from surfaces. These new systems will have enhanced residency time, penetration properties and effectiveness in biofilms. This project intends to under ....Advanced nanotechnologies for targeting biofilms. Advanced nanotechnologies for targeting biofilms. This project aims to develop nano-particulate systems based on a single platform technology that can be delivered as an aerosol. The current lack of a suitable formulation and delivery system hinders the eradication of fungal and bacterial biofilms from surfaces. These new systems will have enhanced residency time, penetration properties and effectiveness in biofilms. This project intends to understand the properties that govern the formation and interactions in these systems, and develop in-vitro tools that the wider scientific community can use. The project expects to generate a single platform that can be used for the eradication of biofilms in numerous applications, from healthcare to agriculture.Read moreRead less
High Gravity Precipitation of Nanoparticles for Pulmonary Drug Delivery. This collaborative project aims to explore the huge market potential of drug delivery by inhalation aerosols using nanoparticles. It will apply cutting edge nanotechnology to develop new techniques using high gravity to synthesise particles of biomaterials suitable for inhalation. Nanoparticles can penetrate deeper into the lung where they deposit and dissolve faster for enhanced therapeutic effects. Successful developme ....High Gravity Precipitation of Nanoparticles for Pulmonary Drug Delivery. This collaborative project aims to explore the huge market potential of drug delivery by inhalation aerosols using nanoparticles. It will apply cutting edge nanotechnology to develop new techniques using high gravity to synthesise particles of biomaterials suitable for inhalation. Nanoparticles can penetrate deeper into the lung where they deposit and dissolve faster for enhanced therapeutic effects. Successful development of the technology will position both Australia and the industry partner to take a lead in the application of this novel technology in pharmaceutical aerosols, and provides better inhalation therapy to benefit patients.Read moreRead less
Economic, social and cross cultural issues in non-pharmaceutical protection of front line responders to pandemic influenza and emerging infections. The protection of front line responders in a pandemic is essential to underpin an effective response. This research is the only work internationally which will address a key gap in evidence. This research has major implications for the national stockpile and for management of front line responders in a pandemic. These data are urgently needed, not ju ....Economic, social and cross cultural issues in non-pharmaceutical protection of front line responders to pandemic influenza and emerging infections. The protection of front line responders in a pandemic is essential to underpin an effective response. This research is the only work internationally which will address a key gap in evidence. This research has major implications for the national stockpile and for management of front line responders in a pandemic. These data are urgently needed, not just in Australia, but globally to inform pandemic planning and disease control policy around emerging infections and bioterrorism.Read moreRead less
Mannitol Powders for Assessment of Asthma in Children. A successful conclusion of this project will enable Australia to become a world leader in childhood asthma assessment. The availability of an objective diagnostic test for early detection of asthma would assist formulating early treatment strategies at this crucial stage in the progression of the disease, improving the quality of life of asthma sufferers in their early years. The Australian pharmaceutical sector will benefit through the ab ....Mannitol Powders for Assessment of Asthma in Children. A successful conclusion of this project will enable Australia to become a world leader in childhood asthma assessment. The availability of an objective diagnostic test for early detection of asthma would assist formulating early treatment strategies at this crucial stage in the progression of the disease, improving the quality of life of asthma sufferers in their early years. The Australian pharmaceutical sector will benefit through the ability to develop proprietary formulations targeted towards taking advantages of the scientific knowledge on pharmaceutical powders and aerosols. The mannitol testing is environmental friendly as powder aerosol delivery does not require any harmful organic solvents to operate.Read moreRead less
Engineering a delivery device and development of a novel formulation for chronic obstructive pulmonary disease and cystic fibrosis. This project will position Australia to become one of the world leaders in the treatment of chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) and other chronic respiratory diseases. The financial burdens of COPD and CF come to at least $900 million a year in Australia alone. These diseases have significant impact on patients and the health system th ....Engineering a delivery device and development of a novel formulation for chronic obstructive pulmonary disease and cystic fibrosis. This project will position Australia to become one of the world leaders in the treatment of chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) and other chronic respiratory diseases. The financial burdens of COPD and CF come to at least $900 million a year in Australia alone. These diseases have significant impact on patients and the health system through regular clinical visits, hospitalisation and employment downtime. The global market for the treatment of COPD is currently more than $8 billion and is expected to increase substantially. The positioning of an Australian pharmaceutical company at the forefront of COPD/CF treatment will have significant national benefits for patients, the health system, and research infrastructure in the field.Read moreRead less
Mechanism of action of an anti-inflammatory compound which targets alternatively activated macrophages. The project will study the mechanism by which a novel anti-inflammatory compound, developed by our commercial partner, suppresses the activity of a population of cells known as alternatively activated macrophages. These cells play a key role in driving allergic inflammation, including the inflammation associated with asthma.
Reduction of Legionnaires' Disease from Cooling Towers. Inhaled water droplets containing Legionella bacteria can cause potentially fatal Legionnaires? disease. Algae are the main source of organic matter in cooling towers on which Legionella feed. If droplets are prevented from leaving the tower they cannot cause disease. If no light enters a cooling tower no algae grow. This project aims to identify and develop designs and measurement methods for cooling towers which give low levels of drople ....Reduction of Legionnaires' Disease from Cooling Towers. Inhaled water droplets containing Legionella bacteria can cause potentially fatal Legionnaires? disease. Algae are the main source of organic matter in cooling towers on which Legionella feed. If droplets are prevented from leaving the tower they cannot cause disease. If no light enters a cooling tower no algae grow. This project aims to identify and develop designs and measurement methods for cooling towers which give low levels of droplets leaving and light entering. The new designs will reduce Legionnaires? disease infections by hundreds of times which eliminates a major urban hazard in Australia.Read moreRead less
The Fluid-Particle Mechanics of a Synthetic Jet-based Dry Powder Inhaler. This project aims to untangle the fundamental principles that govern the fluid mechanics and particulate interactions in a novel concept chip-based micro-zero-net-mass-flux (micro-ZNMF) jet-assisted dry powder inhaler (DPI). Respiratory diseases affect 6.2 million Australians. The treatment of these diseases is hampered by the poor efficiency of current delivery systems, with conventional DPI devices exhibiting sub-optimum ....The Fluid-Particle Mechanics of a Synthetic Jet-based Dry Powder Inhaler. This project aims to untangle the fundamental principles that govern the fluid mechanics and particulate interactions in a novel concept chip-based micro-zero-net-mass-flux (micro-ZNMF) jet-assisted dry powder inhaler (DPI). Respiratory diseases affect 6.2 million Australians. The treatment of these diseases is hampered by the poor efficiency of current delivery systems, with conventional DPI devices exhibiting sub-optimum performance, delivering typically less than 20% of the loaded dose to the target site, the lungs. The new fundamental knowledge resulting from this research will enable the engineering of a high-efficiency groundbreaking DPI, with the potential to be fully adaptive user-specific benefiting millions of Australians. Read moreRead less